BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13379520)

  • 1. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M; JONES WF; NICHOLS RL
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
    [No Abstract]   [Full Text] [Related]  

  • 2. Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus.
    PATTEE PA; BALDWIN JN
    J Bacteriol; 1962 Nov; 84(5):1049-55. PubMed ID: 13941896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.
    LOWBURY EJ; HURST L
    J Clin Pathol; 1959 Mar; 12(2):163-9. PubMed ID: 13641436
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of erythromycin with oleandomycin in combination with other antibiotics against hospital staphylococci.
    ELLIOTT HJ; HALL WH
    J Lab Clin Med; 1959 Mar; 53(3):364-75. PubMed ID: 13631321
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of cross resistance to erythromycin and carbomycin in Micrococcus pyogenes var. aureus.
    HSIE JY; KOTZ R; NUSSER W
    Antibiot Annu; 1955-1956; 3():773-7. PubMed ID: 13355361
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of Proteus mirabilis and its stable L-forms to erythromycin and other macrolides.
    TAUBENECK U
    Nature; 1962 Oct; 196():195-6. PubMed ID: 13993473
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of a combination of sodium sulfisoxazole and oleandomycin phosphate on the development of drug resistance of Micrococcus pyogenes var. aureus in vitro.
    DELORENZO WF
    Antibiot Chemother (Northfield); 1958 Feb; 8(2):84-5. PubMed ID: 24544672
    [No Abstract]   [Full Text] [Related]  

  • 8. Induced resistance of staphylococci to carbomycin and erythromycin.
    RAJAM PC; ADCOCK JD
    Med Bull (Ann Arbor); 1953 Aug; 19(8):212-7. PubMed ID: 13090461
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro antagonism between erythromycin and spiramycin].
    CHABBERT Y
    Ann Inst Pasteur (Paris); 1956 Jun; 90(6):787-90. PubMed ID: 13340322
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
    RANTZ LA; RANDALL E; THUM L; BARKER LF
    Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the antistaphylococcal bacteriostatic activity of 4 antibiotics: erythromycin, spiramycin, oleandomycin and novobiocin].
    BURDIN JC; SCHMITT J; de LAVERGNE
    Rev Med Nancy; 1959 Oct; 84():930-3. PubMed ID: 13806021
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic mixtures; in vitro effect of a tetracycline-oleandomycin mixture (PA 775) on staphylococci.
    Levitt RO; Hubble RH
    N Engl J Med; 1957 Jul; 257(4):180-1. PubMed ID: 13452068
    [No Abstract]   [Full Text] [Related]  

  • 13. Origin of erythromycin-resistant strains of Micrococcus pyogenes in infections; bacteriophage types and in vitro resistance of cultures to antibiotics.
    WISE RI; VOIGT AE; COLLIN MV; CRANNY CL
    AMA Arch Intern Med; 1955 Mar; 95(3):419-26. PubMed ID: 14349420
    [No Abstract]   [Full Text] [Related]  

  • 14. Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.
    HSIE JY; NUSSER W; EPSTEIN S; VAN MAREN H; OZOG S
    Antibiot Chemother (Northfield); 1958 Dec; 8(12):607-14. PubMed ID: 24545054
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro activity of spiramycin in combination with tetracycline, erythromycin, penicillin, streptomycin, on Staphylococcus aureus multiplication, studied by microbiophotometer].
    Mathieu N; Faguet M
    Ann Inst Pasteur (Paris); 1958 Jan; 94(1):69-77. PubMed ID: 13509310
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro activity of sigmamycin: a combination of tetracycline and oleandomycin.
    FAIRBROTHER RW; SOUTHALL JE
    Lancet; 1957 Nov; 273(7003):974-6. PubMed ID: 13482262
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS; AMSTERDAM D
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacterial susceptibility to antibiotics. V. Relative susceptibility of staphylococci and enterococci to erythromycin, carbomycin and a combination of chlortetracycline and chloramphenicol.
    EISENBERG GM; FLIPPIN HF; O'LOUGHLIN JM
    Antibiot Chemother (Northfield); 1953 Oct; 3(10):1026-8. PubMed ID: 24542703
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory studies of oleandomycin (matromycin).
    GERACI JE; NEEDHAM GM
    Antibiotic Med Clin Ther (New York); 1956 Oct; 3(5):334-5. PubMed ID: 13363377
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resistance characteristics in hospital material, with special reference to staphylococcic and enterococcic sensitivity to erythromycin].
    KYLIN O
    Sven Lakartidn; 1956 Sep; 53(36):2259-67. PubMed ID: 13360709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.